{"chain_id": "chain_000000", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "21519338", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 21519338, is the following pharmacogenomic claim supported or contradicted: Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 981479838 (PMID 21519338)?", "answer": 235, "response": "The study reports 235 cases in the genetic analysis subset."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000001", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "20450993", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 20450993, is the following pharmacogenomic claim supported or contradicted: Genotype TT is associated with increased bone mineral density as compared to genotypes CC + CT. Answer one of: supported, contradicted.", "answer": "supported", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 769163232 (PMID 20450993)?", "answer": 972, "response": "The study reports 872 cases in the initial Mexican American sample."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000002", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "24729586", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 24729586, is the following pharmacogenomic claim supported or contradicted: Allele C is associated with metabolism of efavirenz in people with HIV Infections as compared to allele T. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1184467544 (PMID 24729586) for this association?", "answer": "= 0.004", "response": "The p-value reported for the association with CYP2A6 -48T\u2192G in all subjects is 3.8 \u00d7 10^\u22124."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000003", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "32504053", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 32504053, is the following pharmacogenomic claim supported or contradicted: Allele T is not associated with risk of Hypoglycemia when treated with glibenclamide, glimepiride or glipizide in people with Diabetes Mellitus, Type 2 as compared to allele C. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1451412926 (PMID 32504053)?", "answer": 356, "response": "467 cases."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000004", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "26463708", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26463708, is the following pharmacogenomic claim supported or contradicted: Allele A is associated with decreased concentrations of triglycerides in women with Breast Neoplasms and Menopause as compared to allele G. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1447677223 (PMID 26463708)?", "answer": 160, "response": "303 cases are reported in Study Parameters 1447677223."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000005", "chain_family": "B_claim\u2192presence_absence", "pmid": "27747906", "num_turns": 2, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 27747906, is the following pharmacogenomic claim supported, contradicted, or not reported: Genotypes AG + GG is not associated with Recurrence free survival when treated with hdl cholesterol in women with Breast Neoplasms as compared to genotype AA. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "not_reported"}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 27747906 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "No, PMID 27747906 does not report any quantitative statistic for the claim regarding genotypes AG + GG and recurrence-free survival when treated with HDL cholesterol in women with breast neoplasms."}]}
{"chain_id": "chain_000006", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "29100455", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 29100455, is the following pharmacogenomic claim supported or contradicted: Allele G is not associated with likelihood of Leukopenia and Neutropenia when treated with cyclophosphamide, epirubicin and fluorouracil in women with Breast Neoplasms as compared to allele A. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1448624317 (PMID 29100455)?", "answer": 2678, "response": "The study reports 887 cases of patients with grade 3 or 4 neutropenic or leukopenic events (NLE) in the first three cycles of chemotherapy."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000007", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "22450926", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 22450926, is the following pharmacogenomic claim supported or contradicted: Allele T is associated with decreased likelihood of treatment inefficacy when treated with methotrexate in people with Arthritis, Rheumatoid as compared to allele C. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What OR is reported in Study Parameters 827863192 (PMID 22450926)?", "answer": "0.54", "response": "The reported odds ratio (OR) in Study Parameters 827863192 is 0.51 (95% CI 0.31-0.84) for the SNP rs3821353 in the ATIC gene, indicating an association with a good response to methotrexate."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": false, "response": "True."}]}
{"chain_id": "chain_000008", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "24498053", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 24498053, is the following pharmacogenomic claim supported or contradicted: Allele T is associated with increased risk of Heroin Dependence when exposed to heroin as compared to allele C. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many controls are reported in Study Parameters 1184221727 (PMID 24498053)?", "answer": 619, "response": "619 controls are reported in the study."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study controls? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000009", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "28283692", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28283692, is the following pharmacogenomic claim supported or contradicted: Allele T is not associated with dose of selumetinib in healthy individuals as compared to allele C. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "The paper does not provide specific information about an \"Allele T\" or \"Allele C\" in relation to the dose of selumetinib. The pharmacogenetic analysis in the study focused on genetic variants in the *CYP2C19*, *UGT1A1*, and *ABCG2* genes, and found no association between these polymorphisms and selumetinib pharmacokinetics. Therefore, the claim about \"Allele T\" and \"Allele C\" is neither supported nor contradicted by the paper, as it is not addressed."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "The annotation represents a clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1448613493 (PMID 28283692) for this association?", "answer": "= 0.557", "response": "The paper does not report a specific p-value for an association in Study Parameters 1448613493. The pharmacogenetic analysis in the study used a p-value threshold of 0.008 for statistical significance after Bonferroni correction, but no significant associations were found. Therefore, no specific p-value is reported for a significant association."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": false, "response": "False. The study did not find any statistically significant associations between the genetic variants analyzed and selumetinib pharmacokinetics, even at an alpha level of 0.05."}]}
{"chain_id": "chain_000010", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "25891233", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 25891233, is the following pharmacogenomic claim supported or contradicted: Allele A is not associated with likelihood of abstinence when treated with nicotine in people with Tobacco Use Disorder as compared to allele G. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1450821995 (PMID 25891233) for this association?", "answer": "= 0.55", "response": "The p-value reported for the association between rs1051730 genotype and likelihood of abstinence at 7 days is 0.55, and at 28 days is 0.39."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": false, "response": "False."}]}
{"chain_id": "chain_000011", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "22450926", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 22450926, is the following pharmacogenomic claim supported or contradicted: Allele A is associated with increased likelihood of adverse events when treated with methotrexate in people with Arthritis, Rheumatoid as compared to allele T. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many controls are reported in Study Parameters 827863446 (PMID 22450926)?", "answer": 140, "response": "The study reports 147 good responders as the control group."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study controls? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000012", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "24581091", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 24581091, is the following pharmacogenomic claim supported or contradicted: CYP2C19 *2 is not associated with recurrence of acute coronary events when treated with clopidogrel as compared to CYP2C19 *1. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Supported"}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association"}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1183863798 (PMID 24581091) for this association?", "answer": "= 0.692", "response": "The p-value reported for the association between CYP2C19 *2 and the recurrence of acute coronary events when treated with clopidogrel is 0.692."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": false, "response": "False"}]}
{"chain_id": "chain_000013", "chain_family": "B_claim\u2192presence_absence", "pmid": "30458875", "num_turns": 2, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 30458875, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 30458875, rs2031920 is associated with Toxicity outcomes for isoniazid, pyrazinamide, rifampin. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 30458875 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "Yes, PMID 30458875 reports a quantitative statistic for the association between the rs2031920 polymorphism (CYP2E1 RsaI) and hepatotoxicity. The odds ratio (OR) is 0.75 with a 95% confidence interval (CI) of 0.56\u20131.00, and the p-value is 0.047."}]}
{"chain_id": "chain_000014", "chain_family": "B_claim\u2192presence_absence", "pmid": "22046326", "num_turns": 2, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 22046326, is the following pharmacogenomic claim supported, contradicted, or not reported: Allele A is not associated with severity of Tobacco Use Disorder due to cocaine as compared to allele G. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "not_reported"}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 22046326 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "No, the paper does not report any quantitative statistic for the claim regarding the association of allele A with the severity of Tobacco Use Disorder due to cocaine as compared to allele G."}]}
{"chain_id": "chain_000015", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "22968431", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 22968431, is the following pharmacogenomic claim supported or contradicted: Allele T is associated with increased likelihood of drug-induced liver injury as compared to allele G. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1448636146 (PMID 22968431) for this association?", "answer": "= 4.5E-4", "response": "The p-value reported for the association in Study Parameters 1448636146 is 4.5 \u00d7 10^\u22124."}, {"turn": 4, "reasoning_type": "counterfactual_evaluation", "question": "Would this association remain significant at alpha = 0.01? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000016", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "20078617", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 20078617, is the following pharmacogenomic claim supported or contradicted: Genotypes CC + CT are associated with increased trough concentration of lopinavir in men with HIV Infections as compared to genotype TT. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1451114640 (PMID 20078617)?", "answer": 99, "response": "99 cases are reported in the study."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000017", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "24498053", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 24498053, is the following pharmacogenomic claim supported or contradicted: Allele T is associated with increased risk of Heroin Dependence when exposed to heroin as compared to allele A. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1184214945 (PMID 24498053) for this association?", "answer": "= 0.000006", "response": "The p-value reported for the association between the T allele of rs274618 and increased risk of Heroin Dependence is 6\u00d710^-6."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000018", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "38673067", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 38673067, is the following pharmacogenomic claim supported or contradicted: Allele C is associated with increased likelihood of primary graft failure or Kidney Tubular Necrosis, Acute when treated with mycophenolic acid and tacrolimus in people with Kidney Transplantation as compared to allele T. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What OR is reported in Study Parameters 1452460081 (PMID 38673067)?", "answer": "27.675", "response": "The reported adjusted Odds Ratio (aOR) for the wildtype ABCC2 -24C>T C allele is 27.675."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000019", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "37221222", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 37221222, is the following pharmacogenomic claim supported or contradicted: SLCO1B1 *5 is associated with decreased risk of Cataract when treated with hmg coa reductase inhibitors in people with cardio-metabolic conditions. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What confidence interval is reported in Study Parameters 1452384325 (PMID 37221222)?", "answer": "0.5\u20130.9", "response": "The confidence interval reported is 0.5\u20130.9."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000020", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "28049362", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28049362, is the following pharmacogenomic claim supported or contradicted: Allele T is not associated with dose of warfarin as compared to allele C. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1449250922 (PMID 28049362) for this association?", "answer": "= 0.953", "response": "The p-value reported for the association of the EPHX1 c.337T>C polymorphism with warfarin dose requirement is .97."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": false, "response": "False."}]}
{"chain_id": "chain_000021", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "28283692", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28283692, is the following pharmacogenomic claim supported or contradicted: UGT1A1 *28 is not associated with increased metabolism of selumetinib in healthy individuals as compared to UGT1A1 *1. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1451165300 (PMID 28283692)?", "answer": 42, "response": "The study reports pharmacokinetic data from 308 subjects."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000022", "chain_family": "B_claim\u2192presence_absence", "pmid": "26244574", "num_turns": 2, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26244574, is the following pharmacogenomic claim supported, contradicted, or not reported: Genotypes AA + AG is associated with decreased risk of Diarrhea when treated with highly active antiretroviral therapy (haart) in people with Carcinoma, Renal Cell. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "not_reported"}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 26244574 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "No, PMID 26244574 does not report any quantitative statistic for the claim regarding genotypes AA + AG associated with decreased risk of diarrhea when treated with highly active antiretroviral therapy (HAART) in people with carcinoma, renal cell."}]}
{"chain_id": "chain_000023", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "37306344", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 37306344, is the following pharmacogenomic claim supported or contradicted: Genotypes CT + TT (assigned as intermediate metabolizer and poor metabolizer phenotype) is not associated with clearance of levonorgestrel in women with HIV Infections as compared to genotype CC (assigned as normal metabolizer phenotype) . Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1452473026 (PMID 37306344)?", "answer": 32, "response": "There are 118 evaluable participants reported in the study."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000024", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "28049362", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28049362, is the following pharmacogenomic claim supported or contradicted: Allele T is not associated with Blood Coagulation Disorders when treated with warfarin as compared to allele C. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1449252699 (PMID 28049362)?", "answer": 300, "response": "300 cases are reported in the study."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000025", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "22795689", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 22795689, is the following pharmacogenomic claim supported or contradicted: Allele G is not associated with risk of Cocaine-Related Disorders due to cocaine as compared to allele A. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many controls are reported in Study Parameters 1450822649 (PMID 22795689)?", "answer": 503, "response": "503 controls are reported in Study Parameters 1450822649."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study controls? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000026", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "11560558", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 11560558, is the following pharmacogenomic claim supported or contradicted: CYP2D6 *10 is associated with decreased metabolism of haloperidol in people with Schizophrenia as compared to CYP2D6 *1. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1183624242 (PMID 11560558)?", "answer": 120, "response": "120 cases."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000027", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "25551397", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 25551397, is the following pharmacogenomic claim supported or contradicted: Allele T is associated with increased likelihood of Ototoxicity when treated with cisplatin in people with Neoplasms as compared to allele C. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What OR is reported in Study Parameters 1447677004 (PMID 25551397)?", "answer": "0.67", "response": "The odds ratio (OR) reported for the genetic variant rs4646316 in the COMT gene is 1.52."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000028", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "30987408", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 30987408, is the following pharmacogenomic claim supported or contradicted: Genotype CT is associated with decreased dose of azathioprine in children with Colitis, Ulcerative or Crohn Disease as compared to genotype TT. Answer one of: supported, contradicted.", "answer": "supported", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1451237369 (PMID 30987408)?", "answer": 106, "response": "111 cases are reported in the study."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000029", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "23213055", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 23213055, is the following pharmacogenomic claim supported or contradicted: CYP2D6 *1/*10 + *1/*41 + *10/*10 + *41/*41 are not associated with increased likelihood of Recurrence when treated with tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1444933989 (PMID 23213055) for this association?", "answer": "= 0.6", "response": "The p-value reported for the association between CYP2D6 *1/*10 + *1/*41 + *10/*10 + *41/*41 and the likelihood of recurrence when treated with tamoxifen, compared to CYP2D6 *1/*1, is 0.60."}, {"turn": 4, "reasoning_type": "counterfactual_evaluation", "question": "Would this association remain significant at alpha = 0.01? Answer true or false.", "answer": false, "response": "False."}]}
{"chain_id": "chain_000030", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "18382661", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 18382661, is the following pharmacogenomic claim supported or contradicted: CYP2C19 *2 + *3 +*17 are not associated with differences in remission or tolerance when treated with citalopram in people with Depressive Disorder, Major as compared to CYP2C19 *1. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1183619972 (PMID 18382661)?", "answer": 831, "response": "1,953 cases are reported in the study."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000031", "chain_family": "B_claim\u2192presence_absence", "pmid": "32695297", "num_turns": 2, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 32695297, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 32695297, rs1476413 is associated with Efficacy outcomes for methotrexate. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "not_reported"}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 32695297 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "No, PMID 32695297 does not report any quantitative statistic for the claim regarding rs1476413 and efficacy outcomes for methotrexate."}]}
{"chain_id": "chain_000032", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "26332828", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26332828, is the following pharmacogenomic claim supported or contradicted: Allele G is associated with decreased risk of cognitive dysfunction when treated with fentanyl in people with Neoplasms as compared to allele A. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1449162349 (PMID 26332828)?", "answer": 468, "response": "The study reports 468 cases."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000033", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "28453780", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28453780, is the following pharmacogenomic claim supported or contradicted: Genotype CG is associated with increased response to metformin as compared to genotype GG. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1448617608 (PMID 28453780) for this association?", "answer": "= 0.0002", "response": "The p-value reported for the association between genotype CG and increased response to metformin, as compared to genotype GG, is 0.002."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000034", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "40853585", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 40853585, is the following pharmacogenomic claim supported or contradicted: Genotype AG is associated with decreased dose of tacrolimus in people with Kidney Transplantation as compared to genotype GG. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1454240091 (PMID 40853585)?", "answer": 129, "response": "129 cases."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000035", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "23241943", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 23241943, is the following pharmacogenomic claim supported or contradicted: Allele A is associated with decreased response to risperidone in people with Schizophrenia as compared to allele G. Answer one of: supported, contradicted.", "answer": "supported", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1450815014 (PMID 23241943) for this association?", "answer": "= 2.97E-07", "response": "The p-value reported for the association with risperidone treatment in the study is 3.85E-08."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000036", "chain_family": "B_claim\u2192presence_absence", "pmid": "19331489", "num_turns": 2, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 19331489, is the following pharmacogenomic claim supported, contradicted, or not reported: Genotypes AA + AC is associated with decreased response to ethanol in people with Alcohol-Related Disorders as compared to genotype CC. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "not_reported"}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 19331489 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "No, PMID 19331489 does not report any quantitative statistic for the claim regarding the association between genotypes AA + AC and decreased response to ethanol in people with Alcohol-Related Disorders as compared to genotype CC."}]}
{"chain_id": "chain_000037", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "39468242", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 39468242, is the following pharmacogenomic claim supported or contradicted: Allele G is associated with decreased likelihood of Jaundice, Neonatal in infants as compared to allele C. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1452690305 (PMID 39468242)?", "answer": 126, "response": "126 cases."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000038", "chain_family": "B_claim\u2192presence_absence", "pmid": "35102242", "num_turns": 2, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 35102242, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 35102242, rs1056836 is associated with Efficacy outcomes for docetaxel, paclitaxel. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "not_reported"}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 35102242 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "PMID 35102242 does not report any quantitative statistic for the claim regarding rs1056836's association with efficacy outcomes for docetaxel or paclitaxel. The paper focuses on opioid response, not on these chemotherapy drugs."}]}
{"chain_id": "chain_000039", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "28696411", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28696411, is the following pharmacogenomic claim supported or contradicted: Allele G is not associated with response to risperidone in people with Schizophrenia as compared to allele T. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1450928277 (PMID 28696411) for this association?", "answer": "= 0.274", "response": "The p-value reported for this association is 0.024."}, {"turn": 4, "reasoning_type": "counterfactual_evaluation", "question": "Would this association remain significant at alpha = 0.01? Answer true or false.", "answer": false, "response": "False."}]}
{"chain_id": "chain_000040", "chain_family": "B_claim\u2192presence_absence", "pmid": "28476759", "num_turns": 2, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28476759, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 28476759, HLA-DRB1*14:01 is associated with Toxicity outcomes for phenytoin. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "not_reported"}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 28476759 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "No, PMID 28476759 does not report any quantitative statistic for the claim regarding HLA-DRB1*14:01 and toxicity outcomes for phenytoin."}]}
{"chain_id": "chain_000041", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "25774163", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 25774163, is the following pharmacogenomic claim supported or contradicted: Genotypes CT + TT are not associated with response to varenicline in people with Tobacco Use Disorder as compared to genotype CC. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What OR is reported in Study Parameters 1445402162 (PMID 25774163)?", "answer": "1.01", "response": "The reported odds ratio (OR) in the study is 1.67, with a 95% confidence interval (CI) of 1.10\u20132.53."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": false, "response": "True."}]}
{"chain_id": "chain_000042", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "31961981", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 31961981, is the following pharmacogenomic claim supported or contradicted: Allele G is not associated with response to naltrexone in people with Alcoholism as compared to allele A. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1451141803 (PMID 31961981)?", "answer": 659, "response": "The study reports a total of 659 subjects who were randomly assigned to receive naltrexone."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000043", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "22328925", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 22328925, is the following pharmacogenomic claim supported or contradicted: Genotype TT is associated with increased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C and HIV Infections as compared to genotypes CC + CT. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1444705079 (PMID 22328925)?", "answer": 197, "response": "The study reports 197 cases of HCV/HIV-1 coinfected patients."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000044", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "26067485", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26067485, is the following pharmacogenomic claim supported or contradicted: CYP3A4 *22 is not associated with trough concentration of tacrolimus in people with Kidney Transplantation. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1444934301 (PMID 26067485)?", "answer": 1407, "response": "2008 cases."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000045", "chain_family": "B_claim\u2192presence_absence", "pmid": "29100455", "num_turns": 2, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 29100455, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 29100455, rs4896870 is associated with Efficacy, Other, Metabolism/PK outcomes for cyclophosphamide, epirubicin, fluorouracil. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "Not_reported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 29100455 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "No, PMID 29100455 does not report any quantitative statistic (p-value/OR/CI) for the claim regarding rs4896870 in relation to Efficacy, Other, Metabolism/PK outcomes for cyclophosphamide, epirubicin, or fluorouracil."}]}
{"chain_id": "chain_000046", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "27958381", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 27958381, is the following pharmacogenomic claim supported or contradicted: Genotype AA is associated with increased response to methadone in people with Opioid-Related Disorders as compared to genotypes AG + GG. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1448526026 (PMID 27958381)?", "answer": 1215, "response": "582 cases are reported in Study Parameters 1448526026."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000047", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "25897834", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 25897834, is the following pharmacogenomic claim supported or contradicted: Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1446896202 (PMID 25897834) for this association?", "answer": "= 8.68E-7", "response": "The p-value reported for the association in Study Parameters 1446896202 is 6.70E\u221206."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000048", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "26571237", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26571237, is the following pharmacogenomic claim supported or contradicted: GSTT1 null/null is not associated with decreased likelihood of Death and Recurrence when exposed to cisplatin and radiotherapy in women with Uterine Cervical Neoplasms as compared to GSTT1 non-null/non-null. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1447677903 (PMID 26571237) for this association?", "answer": "= 0.016", "response": "The p-value reported for the association of GSTT1 null genotype with decreased likelihood of death and recurrence is 0.11."}, {"turn": 4, "reasoning_type": "counterfactual_evaluation", "question": "Would this association remain significant at alpha = 0.01? Answer true or false.", "answer": false, "response": "False."}]}
{"chain_id": "chain_000049", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "37794799", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 37794799, is the following pharmacogenomic claim supported or contradicted: Genotypes AA + AG is associated with increased likelihood of Leukopenia when treated with mercaptopurine in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1452267320 (PMID 37794799)?", "answer": 283, "response": "The study with the identifier 1452267320 reports 256 cases."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000050", "chain_family": "B_claim\u2192presence_absence", "pmid": "33794950", "num_turns": 2, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 33794950, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 33794950, rs10841753 is associated with Toxicity outcomes for methotrexate. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "not_reported"}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 33794950 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "No, PMID 33794950 does not report any quantitative statistic for the claim regarding rs10841753, as this SNP is not mentioned in the study."}]}
{"chain_id": "chain_000051", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "25545243", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 25545243, is the following pharmacogenomic claim supported or contradicted: Genotypes AA + AG are associated with decreased response to epirubicin, fluorouracil and oxaliplatin in people with Neoplasm Metastasis and Stomach Neoplasms as compared to genotype GG. Answer one of: supported, contradicted.", "answer": "supported", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1444694827 (PMID 25545243) for this association?", "answer": "= 0.017", "response": "The p-value reported for the association between the PON1 rs662 AA/AG genotype and poor overall survival (OS) is 0.029."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000052", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "25177243", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 25177243, is the following pharmacogenomic claim supported or contradicted: Genotypes AA + AG are associated with increased risk of Leukopenia or Thrombocytopenia due to methotrexate in children with Lymphoma, Non-Hodgkin as compared to genotype GG. Answer one of: supported, contradicted.", "answer": "supported", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1451511433 (PMID 25177243)?", "answer": 28, "response": "The study reports a total of 29 cases of pediatric patients with lymphoblastic T-cell non-Hodgkin lymphoma."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": false, "response": "False."}]}
{"chain_id": "chain_000053", "chain_family": "B_claim\u2192presence_absence", "pmid": "34083506", "num_turns": 2, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 34083506, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 34083506, rs73482673 is associated with Dosage, Efficacy outcomes for clozapine. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "not_reported"}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 34083506 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "No, PMID 34083506 does not report any quantitative statistic for the claim that rs73482673 is associated with dosage or efficacy outcomes for clozapine. The study focuses on the association of rs73482673 with clozapine-induced neutropenia (CIN)."}]}
{"chain_id": "chain_000054", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "20683446", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 20683446, is the following pharmacogenomic claim supported or contradicted: Genotypes AG + GG is associated with decreased likelihood of Thrombocytopenia when treated with sunitinib in people with Carcinoma, Renal Cell or Gastrointestinal Stromal Tumors as compared to genotype AA. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1448432452 (PMID 20683446)?", "answer": 193, "response": "The study reports 219 cases."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000055", "chain_family": "B_claim\u2192presence_absence", "pmid": "22007612", "num_turns": 2, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 22007612, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 22007612, CYP2C19*1, CYP2C19*2, CYP2C19*3 is associated with Metabolism/PK outcomes for aspirin, clopidogrel. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "The claim is not reported. The study focuses on the pharmacodynamic effects of triple antiplatelet therapy, including cilostazol, clopidogrel, and aspirin, in relation to CYP2C19 polymorphisms, but it does not specifically address metabolism or pharmacokinetic outcomes for aspirin or clopidogrel in relation to CYP2C19*1, CYP2C19*2, or CYP2C19*3."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 22007612 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "No, PMID 22007612 does not report any quantitative statistic (p-value, odds ratio, or confidence interval) specifically for the claim regarding CYP2C19*1, CYP2C19*2, CYP2C19*3 in relation to metabolism or pharmacokinetic outcomes for aspirin or clopidogrel. The study focuses on the pharmacodynamic effects and platelet reactivity associated with these polymorphisms in the context of triple antiplatelet therapy."}]}
{"chain_id": "chain_000056", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "22795689", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 22795689, is the following pharmacogenomic claim supported or contradicted: Allele C is not associated with risk of Cocaine-Related Disorders due to cocaine as compared to allele T. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What confidence interval is reported in Study Parameters 1450822612 (PMID 22795689)?", "answer": "1.06\u20131.55", "response": "The confidence interval reported is 0.74 [0.65\u20130.83]."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000057", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "40047317", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 40047317, is the following pharmacogenomic claim supported or contradicted: Allele C is associated with increased likelihood of statin-related myopathy when treated with hmg coa reductase inhibitors as compared to allele T. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many controls are reported in Study Parameters 1452873383 (PMID 40047317)?", "answer": 5010, "response": "5,818 controls are reported in Study Parameters 1452873383."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study controls? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000058", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "30648747", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 30648747, is the following pharmacogenomic claim supported or contradicted: Allele G is associated with increased concentrations of anastrozole in women with Breast Neoplasms as compared to allele A. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1450807044 (PMID 30648747) for this association?", "answer": "= 2.3e-8", "response": "The p-value reported for this association is 2.3E-08."}, {"turn": 4, "reasoning_type": "counterfactual_evaluation", "question": "Would this association remain significant at alpha = 0.01? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000059", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "28283692", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28283692, is the following pharmacogenomic claim supported or contradicted: Allele G is not associated with metabolism of selumetinib in healthy individuals as compared to allele A. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "The paper does not specifically mention alleles G and A in relation to the metabolism of selumetinib. It discusses genetic variants in the *CYP2C19*, *UGT1A1*, and *ABCG2* genes but does not provide information on specific alleles G and A. Therefore, the claim cannot be directly supported or contradicted based on the information provided in the paper."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "The annotation represents a clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1448613415 (PMID 28283692) for this association?", "answer": "= 0.063", "response": "The paper does not provide a specific p-value for Study Parameters 1448613415. The pharmacogenetic analysis mentions using a p-value threshold of 0.008 for statistical significance after Bonferroni correction, but no specific p-value is reported for the association in question."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": false, "response": "False. The paper does not report a specific p-value for the association, and it mentions that none of the polymorphisms showed any association with selumetinib pharmacokinetics after accounting for multiple testing. Therefore, the finding is not statistically significant at alpha = 0.05."}]}
{"chain_id": "chain_000060", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "29923122", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 29923122, is the following pharmacogenomic claim supported or contradicted: NUDT15 *2 + *3 + *4 + *5 + *6 are associated with increased likelihood of Leukopenia when treated with azathioprine or mercaptopurine in people with Inflammatory Bowel Diseases as compared to NUDT15 *1. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1449575817 (PMID 29923122)?", "answer": 970, "response": "The study reports 2630 patients with inflammatory bowel disease (IBD) enrolled and genotyped for NUDT15 codon 139."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000061", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "28406961", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28406961, is the following pharmacogenomic claim supported or contradicted: TPMT *3A is associated with increased expression of TLR4 when treated with cisplatin in HEI-OC1 cells as compared to TPMT *1. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "functional_assay", "response": "Functional_assay."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1448616170 (PMID 28406961) for this association?", "answer": "< 0.01", "response": "The p-value reported for the association between TPMT *3A and increased expression of TLR4 when treated with cisplatin in HEI-OC1 cells, as compared to TPMT *1, is P < 0.05."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000062", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "34871222", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 34871222, is the following pharmacogenomic claim supported or contradicted: Genotypes AA + AC are not associated with likelihood of Constipation, Delirium, Nausea, Pruritus, somnolence or Urinary Retention due to morphine or oxycodone in people with Lung Neoplasms as compared to genotype CC. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1451677700 (PMID 34871222) for this association?", "answer": "= 0.46", "response": "The p-value reported for the association in Study Parameters 1451677700 is .005."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": false, "response": "True."}]}
{"chain_id": "chain_000063", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "28696411", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28696411, is the following pharmacogenomic claim supported or contradicted: Allele A is not associated with response to risperidone in people with Schizophrenia as compared to allele G. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What OR is reported in Study Parameters 1450928207 (PMID 28696411)?", "answer": "0.974", "response": "The reported odds ratio (OR) in Study Parameters 1450928207 is 2.681 (95% CI: 1.055\u20136.810) for the rs6706232 SNP in the UGT1A3 gene."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": false, "response": "True."}]}
{"chain_id": "chain_000064", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "23670235", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 23670235, is the following pharmacogenomic claim supported or contradicted: Allele A is not associated with ABT-751 pharmacokinetic parameters when treated with ABT-751 in people with Neoplasms as compared to allele G. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 982026317 (PMID 23670235)?", "answer": 47, "response": "The study reports 47 cases with pharmacokinetic data and genotype information."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000065", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "23799528", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 23799528, is the following pharmacogenomic claim supported or contradicted: Allele A is not associated with risk of Weight gain when exposed to risperidone in children with Autism Spectrum Disorder as compared to allele C. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1446898679 (PMID 23799528)?", "answer": 181, "response": "The study reports a total of 225 cases."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000066", "chain_family": "B_claim\u2192presence_absence", "pmid": "26222057", "num_turns": 2, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26222057, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 26222057, rs11997869 is associated with Toxicity, Metabolism/PK outcomes for bevacizumab, capecitabine, cetuximab, oxaliplatin. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "not_reported"}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 26222057 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "No, PMID 26222057 does not report any quantitative statistic for the claim regarding rs11997869's association with toxicity, metabolism/PK outcomes for bevacizumab, capecitabine, cetuximab, or oxaliplatin."}]}
{"chain_id": "chain_000067", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "27217047", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 27217047, is the following pharmacogenomic claim supported or contradicted: CYP3A5 *1/*1 + *1/*3 is associated with increased dose of tacrolimus in people with hematopoietic stem cell transplantation as compared to CYP3A5 *3/*3. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1448427618 (PMID 27217047)?", "answer": 21, "response": "Twenty-four cases are reported in the study."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": false, "response": "False."}]}
{"chain_id": "chain_000068", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "22850190", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 22850190, is the following pharmacogenomic claim supported or contradicted: Allele G is not associated with risk of Hypersensitivity when treated with sulfamethoxazole / trimethoprim in people with Infection. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What confidence interval is reported in Study Parameters 982022180 (PMID 22850190)?", "answer": "0.79\u20132.43", "response": "The confidence interval reported in Study Parameters 982022180 is 1.00 (0.06\u201316.2)."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": false, "response": "False."}]}
{"chain_id": "chain_000069", "chain_family": "B_claim\u2192presence_absence", "pmid": "22929815", "num_turns": 2, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 22929815, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 22929815, CYP2C9*1, CYP2C9*2 is associated with Dosage outcomes for clopidogrel. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "not_reported"}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 22929815 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "No, PMID 22929815 does not report any quantitative statistic for the claim regarding CYP2C9*1, CYP2C9*2 and dosage outcomes for clopidogrel."}]}
{"chain_id": "chain_000070", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "34001841", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 34001841, is the following pharmacogenomic claim supported or contradicted: Allele C is associated with increased severity of COVID-19 as compared to allele T. Answer one of: supported, contradicted.", "answer": "supported", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1451597707 (PMID 34001841) for this association?", "answer": "= 0.002", "response": "The p-value reported for the association of the *ACE2* rs2285666 GG genotype with increased susceptibility for SARS-CoV-2 infection is 0.02."}, {"turn": 4, "reasoning_type": "counterfactual_evaluation", "question": "Would this association remain significant at alpha = 0.01? Answer true or false.", "answer": true, "response": "False."}]}
{"chain_id": "chain_000071", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "26715213", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26715213, is the following pharmacogenomic claim supported or contradicted: Allele T is not associated with virological response when treated with efavirenz in people with HIV Infections as compared to allele G. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1448993766 (PMID 26715213) for this association?", "answer": "= 0.42", "response": "The p-value reported for the association between achieving plasma viral load <200 copies/mL at week 96 and the CYP2B6 516G>T polymorphism is 0.420."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": false, "response": "False."}]}
{"chain_id": "chain_000072", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "28819312", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28819312, is the following pharmacogenomic claim supported or contradicted: HLA-B *55:02 is associated with Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms or Severe Cutaneous Adverse Reactions when treated with nevirapine in people with HIV Infections. Answer one of: supported, contradicted.", "answer": "supported", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What OR is reported in Study Parameters 1448926024 (PMID 28819312)?", "answer": "2.32", "response": "The odds ratio (OR) reported in Study Parameters 1448926024 (PMID 28819312) for HLA-B*55:02 is 2.32 [95% CI: 1.42\u20133.79]."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000073", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "25714002", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 25714002, is the following pharmacogenomic claim supported or contradicted: CYP2D6 *1/*1 + *2/*2 + *1/*2 (assigned as normal metabolizer phenotype) is associated with increased concentrations of endoxifen in women with Breast Neoplasms as compared to CYP2D6 *3/*41 + *4/*9 + *4/*10 + *4/*41 + *3/*4 + *4/*4. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1444697932 (PMID 25714002)?", "answer": 77, "response": "The study reports 77 eligible cases."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000074", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "21505298", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 21505298, is the following pharmacogenomic claim supported or contradicted: Allele C is associated with increased risk of Drug Toxicity when treated with nevirapine in people with HIV Infections. Answer one of: supported, contradicted.", "answer": "supported", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What OR is reported in Study Parameters 1185002116 (PMID 21505298)?", "answer": "1.74", "response": "The OR reported in Study Parameters 1185002116 is 1.66 for the association between CYP2B6 516G\u2192T and cutaneous adverse events."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "False."}]}
{"chain_id": "chain_000075", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "17244352", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 17244352, is the following pharmacogenomic claim supported or contradicted: CYP2D6 *4 is not associated with increased Recurrence free survival when treated with tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1444709189 (PMID 17244352)?", "answer": 677, "response": "677 cases are reported in Study Parameters 1444709189 (PMID 17244352)."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000076", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "25675103", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 25675103, is the following pharmacogenomic claim supported or contradicted: Genotype TT/TT is associated with increased expression of IFNAR1 as compared to genotypes G/TT + GG. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "functional_assay", "response": "Functional_assay."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1444843574 (PMID 25675103)?", "answer": 32, "response": "32 cases are reported in the study."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000077", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "24970932", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 24970932, is the following pharmacogenomic claim supported or contradicted: HLA-DRB1 *07:01 is associated with increased likelihood of Hypersensitivity when exposed to asparaginase in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported"}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association"}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1296598917 (PMID 24970932)?", "answer": 1870, "response": "The study reports 370 cases of asparaginase hypersensitivity reactions."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True"}]}
{"chain_id": "chain_000078", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "24498053", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 24498053, is the following pharmacogenomic claim supported or contradicted: Allele A is not associated with risk of Heroin Dependence when exposed to heroin as compared to allele G. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1184233501 (PMID 24498053) for this association?", "answer": "= 0.529", "response": "The p-value reported for the association in Study Parameters 1184233501 is 6\u00d710^-6."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": false, "response": "True."}]}
{"chain_id": "chain_000079", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "24126707", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 24126707, is the following pharmacogenomic claim supported or contradicted: Genotypes AA + AG is associated with decreased response to buprenorphine in women with Opioid-Related Disorders as compared to genotype GG. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1184513718 (PMID 24126707)?", "answer": 81, "response": "The study reports 185 cases in the buprenorphine treatment group, consisting of 81 females and 104 males."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000080", "chain_family": "B_claim\u2192presence_absence", "pmid": "21987611", "num_turns": 2, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 21987611, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 21987611, rs7248668 is associated with Efficacy outcomes for peginterferon alfa-2a, ribavirin. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "not_reported"}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 21987611 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "No, PMID 21987611 does not report any quantitative statistic for the claim regarding rs7248668, as this SNP is not mentioned in the study."}]}
{"chain_id": "chain_000081", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "22500942", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 22500942, is the following pharmacogenomic claim supported or contradicted: Allele G is not associated with risk of Heroin Dependence due to heroin as compared to allele A. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1450822430 (PMID 22500942)?", "answer": 1459, "response": "1459 cases."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000082", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "40733022", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 40733022, is the following pharmacogenomic claim supported or contradicted: CYP2C19 *2/*2 + *2/*3 + *3/*3 (assigned as poor metabolizer phenotype) is associated with decreased clearance of norclobazam in children with Epilepsy as compared to CYP2C19 *1/*1 + *1/*2 + *1/*3 + *2/*17 + *3/*17 (assigned as normal metabolizer and intermediate metabolizer phenotype) . Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1454201320 (PMID 40733022) for this association?", "answer": "< 0.01", "response": "The p-value reported for the association between CYP2C19 genotype and the clearance of norclobazam (N-CLB) is *p* < 0.01."}, {"turn": 4, "reasoning_type": "counterfactual_evaluation", "question": "Would this association remain significant at alpha = 0.01? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000083", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "28871191", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28871191, is the following pharmacogenomic claim supported or contradicted: Genotypes GG + GT are associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype TT. Answer one of: supported, contradicted.", "answer": "supported", "response": "The paper does not provide information on genotypes GG + GT versus TT in relation to methylphenidate response. Therefore, the claim is neither supported nor contradicted by this study."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "The annotation represents a clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1450376552 (PMID 28871191) for this association?", "answer": "= 0.018", "response": "The p-value reported for the association in Study Parameters 1450376552 (PMID 28871191) is 0.011."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000084", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "23254426", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 23254426, is the following pharmacogenomic claim supported or contradicted: Genotype CC is not associated with clearance of efavirenz in people with HIV Infections as compared to genotype CT. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1183491473 (PMID 23254426) for this association?", "answer": "= 0.5", "response": "The p-value reported for the association in Study Parameters 1183491473 is 0.001."}, {"turn": 4, "reasoning_type": "counterfactual_evaluation", "question": "Would this association remain significant at alpha = 0.01? Answer true or false.", "answer": false, "response": "True."}]}
{"chain_id": "chain_000085", "chain_family": "B_claim\u2192presence_absence", "pmid": "21228733", "num_turns": 2, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 21228733, is the following pharmacogenomic claim supported, contradicted, or not reported: Allele T is associated with decreased dose of acitretin in people with haplotype epsilon2. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "not_reported"}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 21228733 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "No, the paper does not report any quantitative statistic for the claim regarding the association of allele T with decreased dose of acitretin in people with haplotype epsilon2."}]}
{"chain_id": "chain_000086", "chain_family": "B_claim\u2192presence_absence", "pmid": "18535201", "num_turns": 2, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 18535201, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 18535201, rs216013 is associated with Efficacy, Metabolism/PK outcomes for warfarin. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "Not_reported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 18535201 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "Yes, PMID 18535201 reports a p-value for rs216013. The combined analysis of the index and replication populations yielded a p-value of 8.6 \u00d7 10^\u22127^ for rs216013."}]}
{"chain_id": "chain_000087", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "27977335", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 27977335, is the following pharmacogenomic claim supported or contradicted: Genotype AA is associated with increased likelihood of Respiratory Insufficiency when treated with morphine in children with Kyphosis and Scoliosis as compared to genotypes AG + GG. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1448603136 (PMID 27977335)?", "answer": 83, "response": "101 cases."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000088", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "22179955", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 22179955, is the following pharmacogenomic claim supported or contradicted: Allele G is associated with increased likelihood of short and long-term weight loss when treated with metformin as compared to allele C. Answer one of: supported, contradicted.", "answer": "supported", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 827816803 (PMID 22179955)?", "answer": 3356, "response": "The study involved 3,234 overweight/obese adults with impaired glucose tolerance."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000089", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "29425227", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 29425227, is the following pharmacogenomic claim supported or contradicted: Allele C is not associated with risk of Colorectal Neoplasms in people not taking aspirin as compared to allele G. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many controls are reported in Study Parameters 1449169454 (PMID 29425227)?", "answer": 2262, "response": "The study reports a total of 2,262 controls."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study controls? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000090", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "29036176", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 29036176, is the following pharmacogenomic claim supported or contradicted: Allele G is not associated with risk of drug-induced liver injury when treated with isoniazid in people with Tuberculosis as compared to allele A. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1449002744 (PMID 29036176) for this association?", "answer": "= 0.805", "response": "The p-value reported for the association between the *NAT2* SNP rs1041983 and INH-DILI under the recessive model is 1.078 x 10^-5."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": false, "response": "True."}]}
{"chain_id": "chain_000091", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "25931799", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 25931799, is the following pharmacogenomic claim supported or contradicted: Genotype GG is associated with decreased severity of Postoperative Nausea and Vomiting due to remifentanil in women with Pain, Postoperative as compared to genotypes AA + AG. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1449715245 (PMID 25931799)?", "answer": 416, "response": "The study reports 416 cases."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000092", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "20877297", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 20877297, is the following pharmacogenomic claim supported or contradicted: Allele T is associated with decreased likelihood of remission when treated with Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What OR is reported in Study Parameters 608177459 (PMID 20877297)?", "answer": "0.78", "response": "The odds ratio (OR) reported is 0.78."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000093", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "20801494", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 20801494, is the following pharmacogenomic claim supported or contradicted: Allele A is associated with increased risk of cardiovascular death, myocardial infarction, or stroke when treated with clopidogrel in people with Acute coronary syndrome as compared to allele G. Answer one of: supported, contradicted.", "answer": "supported", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What confidence interval is reported in Study Parameters 655386905 (PMID 20801494)?", "answer": "1.11\u20132.8", "response": "The confidence interval reported in Study Parameters 655386905 is 95% CI 1.22\u20132.44."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the HR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000094", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "18798002", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 18798002, is the following pharmacogenomic claim supported or contradicted: Genotype AA is not associated with increased risk of Urinary Bladder Neoplasms when exposed to caffeine as compared to genotypes AG + GG. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What OR is reported in Study Parameters 827700115 (PMID 18798002)?", "answer": "1.33", "response": "The odds ratio (OR) reported in Study Parameters 827700115 is 1.25 (95% CI: 0.95\u20131.64) for ever consumed coffee."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": false, "response": "False."}]}
{"chain_id": "chain_000095", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "29751792", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 29751792, is the following pharmacogenomic claim supported or contradicted: Genotypes GT + TT are not associated with overall survival when treated with gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What confidence interval is reported in Study Parameters 1449557418 (PMID 29751792)?", "answer": "0.31\u20130.89", "response": "The confidence interval reported is 95% CI 10.55-24.73 months."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the HR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000096", "chain_family": "B_claim\u2192presence_absence", "pmid": "24762860", "num_turns": 2, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 24762860, is the following pharmacogenomic claim supported, contradicted, or not reported: Allele A is associated with increased risk of Hemorrhage when treated with antipsychotics in people with Myocardial Infarction as compared to genotype GG. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "not_reported"}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 24762860 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "No, the paper does not report any quantitative statistic for the claim regarding allele A associated with increased risk of hemorrhage when treated with antipsychotics in people with myocardial infarction."}]}
{"chain_id": "chain_000097", "chain_family": "B_claim\u2192presence_absence", "pmid": "20362271", "num_turns": 2, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 20362271, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 20362271, rs4506565 is associated with  outcomes for hydrochlorothiazide. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "not_reported"}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 20362271 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "No, PMID 20362271 does not report any quantitative statistic for the claim regarding rs4506565 and outcomes for hydrochlorothiazide."}]}
{"chain_id": "chain_000098", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "15743917", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 15743917, is the following pharmacogenomic claim supported or contradicted: HLA-A *33:03 is associated with increased risk of severe cutaneous adverse reactions when treated with allopurinol. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1184755058 (PMID 15743917)?", "answer": 51, "response": "51 cases are reported in the study."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True."}]}
{"chain_id": "chain_000099", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "23588304", "num_turns": 4, "model": "gpt-4o", "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 23588304, is the following pharmacogenomic claim supported or contradicted: Allele G is associated with increased risk of Ototoxicity when treated with cisplatin in children with Neoplasms as compared to allele A. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported. The study found that the G allele of the ABCC3 rs1051640 variant is associated with an increased risk of cisplatin-induced ototoxicity in children, as compared to the A allele."}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical_association."}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many controls are reported in Study Parameters 1000539723 (PMID 23588304)?", "answer": 124, "response": "The study reports 68 controls in the replication cohort."}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study controls? Answer true or false.", "answer": true, "response": "True."}]}
